Five Melanoma Research Highlights to Look Forward to in 2021

By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 13 January 2021 In Allies & Partnerships, News, Prevention, Science, Treatment

At MRA, every day we are focused on how melanoma research can be reimagined to accelerate progress similar to what has been accomplished in record time with COVID-19 research, and look forward to a future not only void of COVID-19; but where suffering and death due to melanoma are no more.

Read More


Creating Art to Create Change: The Power to Heal & Mobilize Community

By Renee Orcione, MRA Development Associate | 11 January 2021 In Allies & Partnerships, Melanoma Stories

Following the initial shock of her diagnosis and the strain of facing treatments on her own, Barbara was faced with yet another hurdle. Her arm surgery had left it nearly immobile. Not only was this a problem for her daily functioning, it made it extremely difficult for Barbara to pursue her lifelong passion of art.

Read More


Reimagining Melanoma Research During and After the Pandemic

By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 1 January 2021 In News, Science

The COVID-19 pandemic has touched all of our lives – from illnesses and unexpected deaths, to world economies and the careers impacted. Like everything else, melanoma research has also been impacted – from decreased enrollment in clinical trials, to research labs hampered by lock-downs and new protocols. At MRA, we contemplate how can melanoma research be reimagined to accelerate progress similar to what has been accomplished with COVID-19.

Read More


Exciting End of Year Melanoma Clinical Trial Results

By Kristen Mueller, Ph.D., MRA Scientific Program Director | 11 December 2020 In Science, Treatment

The annual Society for the Immunotherapy for Cancer (SITC) meeting did not disappoint, despite its virtual format, when it came to new clinical advances for melanoma. Researchers presented data from several important clinical trials and highlighted several novel agents that may boost responses to checkpoint immunotherapy.

Read More


Mary Jo Rogers: Research Will Get Us There

By Cody R. Barnett, MRA Director of Communications | 8 December 2020 In Melanoma Stories

With red hair and fair skin, Mary Jo Rogers has always known she was at high risk for melanoma, so she saw her dermatologist regularly. Despite knowing the risk, her 2011 diagnosis of Stage 3C melanoma still came as a big surprise.

Read More


Gail: Stage 4 to NED (No Evidence of Disease) Through a Clinical Trial

By Cody R. Barnett, MRA Director of Communications | 10 November 2020 In Melanoma Stories

Gail was already on her way out the exam room door, following her annual physical, before she remembered to ask about a dry cough she’d had for about a week.  

Read More


Amy Fights for Acral Melanoma to be Seen

By Cody R. Barnett, MRA Director of Communications | 28 October 2020 In Melanoma Stories

For patients diagnosed with acral melanoma today, Amy offers the following advice: “You aren’t alone. If you find a spot – any spot, really that looks different or concerns you – get it checked out. Advocate for a biopsy because doctors don’t always know what they are looking for when it comes to acral melanoma.”

Read More


Fueling a Revolution: Driving Research Forward

21 October 2020 In Allies & Partnerships, Melanoma Stories, News, Policy, Prevention, Science, Treatment

MRA is powering a revolution in melanoma research. A revolution that is not only benefiting patients with melanoma but also impacting the field of oncology at large.

Read More


Take Life as it Comes

By Cody R. Barnett, MRA Director of Communications | 12 October 2020 In Melanoma Stories

At her local hospital, Karen was told she had both lung and brain cancer. She was in shock – she had been feeling great and was diligent about eating right and exercising. It wasn’t until she met MRA-funded investigator, Dr. Rizwan Haq at Dana-Farber Cancer Institute that she learned that her tumors were actually caused by malignant, stage 4 melanoma. Following radiosurgery and combination immunotherapy, Karen’s melanoma is stable.

Read More


Advancing Acral Melanoma Research

5 October 2020 In Science, Treatment

Patients with acral melanoma, a rare subtype of the disease that develops in the nailbeds, palms, or soles of the feet are particularly underserved by today’s treatments.So, improving outcomes for all advanced melanoma patients will, in part, depend on developing new treatments for acral and other rare subtypes of melanoma like uveal and mucosal melanoma. Those treatments, in turn, will depend on more research on these subtypes that deepens our understanding of what causes them or enables them to flourish.

Read More


Login

×